MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease (L36180) - R12 - Effective July 06, 2023

This Local Coverage Determination (LCD) has been revised under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).

Medicare Coverage Database (MCD) Number: L36180

Effective Date: July 06, 2023

Summary of Changes: Under CMS National Coverage Policy updated section headings for regulations and revised the following regulation: CMS Internet-Only Manual, Pub. 100-02, Medicare Policy Manual, Chapter 15, §80 Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic Tests, to include section 80.1.1. Under Bibliography changes were made to citations to reflect AMA citation guidelines. Formatting, punctuation, and typographical errors were corrected throughout the LCD.

Visit the Active LCDs webpage to view the Active LCD or access it via the CMS MCD.

Last Updated Jul 07 , 2023